Cargando…
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
In general, expression of transglutaminase 2 (TGase 2) is upregulated in renal cell carcinoma (RCC), resulting in p53 instability. Previous studies show that TGase 2 binds to p53 and transports it to the autophagosome. Knockdown or inhibition of TGase 2 in RCC induces p53-mediated apoptosis. Here, w...
Autores principales: | Lee, Seon-Hyeong, Lee, Won-Kyu, Kim, Nayeon, Kang, Joon Hee, Kim, Kyung-Hee, Kim, Seul-Gi, Lee, Jae-Seon, Lee, Soohyun, Lee, Jongkook, Joo, Jungnam, Kwon, Woo Sun, Rha, Sun Young, Kim, Soo-Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267221/ https://www.ncbi.nlm.nih.gov/pubmed/30463244 http://dx.doi.org/10.3390/cancers10110455 |
Ejemplares similares
-
Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC
por: Lee, Soohyun, et al.
Publicado: (2018) -
Transglutaminase 2 Promotes Autophagy by LC3 Induction through p53 Depletion in Cancer Cell
por: Kang, Joon Hee, et al.
Publicado: (2019) -
Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma
por: Lee, Seon-Hyeong, et al.
Publicado: (2020) -
Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma
por: Kang, Joon Hee, et al.
Publicado: (2020) -
Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
por: Lee, Jae-Seon, et al.
Publicado: (2019)